Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.

Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE.

J Intensive Care Med. 2012 May-Jun;27(3):172-8. doi: 10.1177/0885066610396312. Review.

PMID:
21436167
2.

Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).

Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC; Portuguese Community-Acquired Sepsis Study Group..

Crit Care Med. 2009 Feb;37(2):410-6. doi: 10.1097/CCM.0b013e3181958b1c.

PMID:
19114885
3.

Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.

De Backer D, Aldecoa C, Njimi H, Vincent JL.

Crit Care Med. 2012 Mar;40(3):725-30. doi: 10.1097/CCM.0b013e31823778ee.

PMID:
22036860
4.

Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.

Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA.

Shock. 2010 Apr;33(4):375-80. doi: 10.1097/SHK.0b013e3181c6ba6f.

PMID:
19851126
5.

Vasopressors for shock.

Müllner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G.

Cochrane Database Syst Rev. 2004;(3):CD003709. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003709.

PMID:
15266497
6.

[Effectiveness of norepinephrine versus dopamine for septic shock: a meta analysis].

Zhou FH, Song Q.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Aug;25(8):449-54. doi: 10.3760/cma. j. issn.2095-4352.2013.08.001. Chinese.

7.

Effect of norepinephrine on the outcome of septic shock.

Martin C, Viviand X, Leone M, Thirion X.

Crit Care Med. 2000 Aug;28(8):2758-65.

PMID:
10966247
8.

Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.

Oba Y, Lone NA.

J Crit Care. 2014 Oct;29(5):706-10. doi: 10.1016/j.jcrc.2014.04.011. Review.

PMID:
24857641
9.

Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.

Pharmacotherapy. 2004 Aug;24(8):1002-12.

PMID:
15338849
10.

Vasopressors for hypotensive shock.

Gamper G, Havel C, Arrich J, Losert H, Pace NL, Müllner M, Herkner H.

Cochrane Database Syst Rev. 2016 Feb 15;2:CD003709. doi: 10.1002/14651858.CD003709.pub4. Review.

PMID:
26878401
11.

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.

Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A.

PLoS One. 2015 Aug 3;10(8):e0129305. doi: 10.1371/journal.pone.0129305. Review.

12.

Vasopressors for hypotensive shock.

Havel C, Arrich J, Losert H, Gamper G, Müllner M, Herkner H.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003709. doi: 10.1002/14651858.CD003709.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;2:CD003709.

PMID:
21563137
13.

Use of heptaminol hydrochloride for catecholamine weaning in septic shock.

Bahloul M, Chaari A, Ben Mbarek MN, Kallel H, Bouaziz M.

Am J Ther. 2012 Jan;19(1):e8-17. doi: 10.1097/MJT.0b013e3181e9b630.

PMID:
20720484
14.
15.
16.

Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.

Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA.

Crit Care Med. 1993 Jun;21(6):830-8.

PMID:
8504649
17.

Dopamine therapy in septic shock: detrimental effect on survival?

Boulain T, Runge I, Bercault N, Benzekri-Lefevre D, Wolf M, Fleury C.

J Crit Care. 2009 Dec;24(4):575-82. doi: 10.1016/j.jcrc.2008.11.003.

PMID:
19327324
18.

Intravenous immunoglobulin for treating sepsis and septic shock.

Alejandria MM, Lansang MA, Dans LF, Mantaring JB.

Cochrane Database Syst Rev. 2002;(1):CD001090. Review. Update in: Cochrane Database Syst Rev. 2013;9:CD001090.

PMID:
11869591
19.

Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.

Ventura AM, Shieh HH, Bousso A, Góes PF, de Cássia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE.

Crit Care Med. 2015 Nov;43(11):2292-302. doi: 10.1097/CCM.0000000000001260.

PMID:
26323041
20.

Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.

Schmoelz M, Schelling G, Dunker M, Irlbeck M.

J Cardiothorac Vasc Anesth. 2006 Apr;20(2):173-8.

PMID:
16616656

Supplemental Content

Support Center